• Aid loss leads to altered differentiation, transcription, and methylation in specific genetic loci in hematopoietic stem/progenitor cells.
Introduction
Activation-induced cytidine deaminase (AID) has been a focus of intense study for over a decade, since it was shown to have a critical role in generating antibody diversity in B lymphocytes. 1 AID initiates the somatic hypermutation process through deamination of cytidine to uridine in the recombined variable region, followed by removal of the uracil base by uridine DNA glycosylase and DNA repair by several error-prone base-excision repair (BER) and mismatchrepair enzymes. 2 AID further induces the second step of antibody diversification, class-switch recombination, through deamination of bases in the switch region, causing double-strand breaks (DSBs) and recombination. 3 Recent studies have uncovered a critical role for AID in active DNA demethylation in zebrafish, mouse embryos, and mammalian somatic cells. [4] [5] [6] At the same time, a number of studies have identified critical enzymes involved in active DNA demethylation. [5] [6] [7] [8] The first step in demethylation is hydroxylation of 5-methylcytosine (5mC) to form 5-hydroxymethylcytosine (5hmC) and further oxidation to form 5-formylcytosine and 5-carboxylcytosine by the ten-eleven-translocation (TET) family members. The second step is deamination of 5mC or 5hmC to form 5-methyluracil or 5-hydroxymethyluracil by AID/apolipoprotein B messenger RNA (mRNA) editing enzyme, catalytic polypeptide-like (APOBEC) family members. The final step is replacement of 5-methyluracil, 5-hydroxymethyluracil, or 5-carboxylcytosine to cytosine by the uracil DNA glycosylase family of BER glycosylases. 9 Taken together, these studies suggest AID acts downstream of TET family members in mediating active DNA demethylation.
Recent studies using high-throughput genome-wide sequencing have identified somatic deletions and loss-of-function mutations in the TET2 gene in 10% to 20% of patients with myelodysplastic syndromes/ myeloproliferative neoplasms, 10, 11 in 10% to 20% of patients with acute myeloid leukemia (AML), and in 40% to 50% of patients with chronic myelomonocytic leukemia (CMML). 12, 13 In mouse models, conditional loss of Tet2 in the hematopoietic compartment leads to expansion of hematopoietic stem/progenitor cells (HSPCs; Lin , and Aid 2/2 adult mice around 6 months old. Total DNA was extracted from these cells and dot-blot assay was performed to detect 5hmC. Membrane was stained with MB to detect DNA loading control. Blot density was quantified by Image J software using blots derived from 100 ng of DNA. Right bar graph shows the ratio of the 5hmC value to the MB value. The data are mean 6 SD (n 5 3 for each genotype). MB, methylene blue; SPL, spleen.
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Aid +/-Aid -/- For personal use only. on October 3, 2017. by guest www.bloodjournal.org From capacity, and development of myeloproliferative disease. [14] [15] [16] These data clearly indicate the critical role of TET2 in both HSC regulation and myeloid transformation.
AID was reported to induce DSBs at immunoglobulin heavy chain (IgH) translocating partners, including at c-myc/IgH in B-cell lymphoma. 17 Whole-genome sequencing of a variety of human tumors uncovered mutation clusters of ,10 kb in size termed "kataegis," 18 which are predominantly C to T transitions. Of note, kataegic mutations found in human lymphomas derived from germinal center B cells occurred frequently in WRCY hypermutation hotspots, indicating that AID is responsible for kataegic mutations in these cells. 18 In addition, AID was reported to stabilize the pluripotent state in induced pluripotent stem cells (iPSCs) by removing epigenetic memory of pluripotency genes, suggesting the essential role of AID in iPSC reprogramming. 19 Given that AID has multifaceted functions including a role in active DNA demethylation, in lymphomagenesis, and in iPSC regulation, we hypothesized that AID may regulate stem/progenitor self-renewal and differentiation and suppress myeloid transformation. Here, we show that Aid loss in mice leads to alterations in differentiation including increased myeloid expansion and attenuation in erythroid output, but does not induce alterations in self-renewal or in susceptibility to transformation. Consistent with these data, Aid loss in HSPCs causes transcriptional alteration of known regulators of erythropoiesis and enhanced DNA methylation in loci with a known role in transcriptional regulation. These data suggest that AID is a critical regulator in myeloid and erythroid lineage differentiation and a key epigenetic regulator that maintains transcriptional output.
Methods

Mice
Mice with the Aid knockout allele were previously described. 2 The conditional Vav-Cre 1 Tet2 f/f mice and Flt3 ITD mice were previously described. 14, 20 All animal procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the institutional animal care and use committees at Memorial Sloan Kettering Cancer Center.
Human samples
Human bone marrow (BM) samples were obtained from deidentified patients at Hospital for Special Surgery. All patients provided informed consent. Approval was obtained from the institutional review board at Memorial Sloan Kettering Cancer Center and Hospital for Special Surgery.
Statistical analysis
All statistical analyses were performed using the unpaired Student t test. P values ,.05 were considered statistically significant. Additional experimental procedures are described in the supplemental Methods (available on the Blood Web site).
Results
Disrupted Aid expression and enzymatic activity in Aid knockout cells
In order to explore the functional role of Aid in normal and malignant hematopoiesis, we used C57/Bl6 mice with a previously characterized Aid knockout allele. 2 We first collected whole BM cells from either wild-type (WT), Aid Figure 1C ). Because Aid is incorporated in active DNA demethylation by deamination of 5hmC to form 5-hydroxymethyluracil followed by cytosine replacement via BER, 9 we performed dotblot assays against 5hmC using DNA samples derived from either WT, Aid Figure 1D ).
Aid loss causes myeloid expansion and anemia in vivo
To investigate the impact of Aid on normal hematopoiesis, we assessed complete blood counts (CBCs) of WT, Aid Figure 1A) . In order to determine whether Aid loss induces a myeloproliferative phenotype as seen in Tet2 2/2 mice, we euthanized WT, Aid
, and Aid ) compared with WT, consistent with compensatory splenic erythropoiesis in the Aid 2/2 mice which was not sufficient to rescue the anemia phenotype (supplemental Figure 5 ). Taken together, these data indicate that Aid loss causes myeloid expansion and anemia due to altered myeloid/erythroid differentiation but does not cause myeloproliferative disease in vivo.
Aid loss does not affect HSC self-renewal but alters expression of myeloid/erythroid lineage-specific transcription factors
In order to explore the role of Aid on HSC self-renewal, we performed competitive repopulating assays. Whole BM cells from either WT, Figure 3A) . In contrast to the first recipients, Aid 1/2 and Aid 2/2 BM cells lost their competitive advantage in secondary transplantation studies ( Figure 3A) . Notably, the percentages of both the donorderived myelomonocytic compartment (CD45. Figure 3D ; supplemental Figure 6 ). These data suggest that Aid loss in GMPs increases transcriptional output of Cebpa and ablation of Aid in MEPs decreases expression of Gata1, thereby causing skewed differentiation toward the myelomonocytic lineage and impaired erythroid differentiation. 
Tet2
del/del mice compared with WT, however, there was no overall difference in blood counts between Tet2 del/del and Aid
2/2
Tet2 del/del mice (supplemental Figure 7) . Flow cytometric analysis of PB revealed no significant difference in myeloid and lymphoid lineage proportions ( Figure 4A) 
Flt3
ITD/ITD mice (supplemental Figure 8) . Figure 5C ). In methylcellulose (H4434) assays, AID-silenced (sh-1 transduced) cells generated a higher number of GM colonies than scramble cells ( Figure 5D ). Although the number of CFU-E colonies was similar in these 2 arms, the percentage of the CFU-E colony was significantly lower in AID-silenced (sh-1 transduced) cells compared with scramble cells ( Figure 5D ). We also performed the same experiment using another hairpin which effectively silenced AID (sh-3) and confirmed a significantly higher number of GM colonies and a lower percentage of CFU-E colonies in AIDsilenced (sh-3 transduced) cells (supplemental Figure 10) . Of note, CFU-E colonies derived from both scramble cells and AID-silenced cells showed reddish discoloration, suggesting that these colonies are hemoglobinized ( Figure 5E ; supplemental Figure 10 ). These findings are consistent with the expansion of the myelomonocytic compartment seen in Aid 2/2 mice and demonstrate that silencing of human AID has a similar effect on human hematopoietic cell differentiation with a key role in regulating myeloid fate commitment.
Deletion of Aid alters transcription and methylation of hematopoietic regulators and tumor suppressors
Given the putative role of AID/APOBEC family members in mutation clusters called "kataegis," 18 we performed whole-exome sequencing (WES) using DNA from either WT or Aid Figure 11) .
To determine whether Aid loss causes alteration of genome-wide transcription and methylation profile, we performed RNA sequencing (RNA-seq) and enhanced reduced representation bisulfite sequencing (eRRBS) on LSK cells from WT and Aid 2/2 mice. Differential gene expressionanalysisofRNA-seq datarevealedstatisticallysignificantly differentially expressed genes (adjusted P value of ,.05 and |log2 fold change| . 1 [ Figure 6A ; supplemental Figure 12] ). These include decreased expression of Aid in Aid 2/2 LSKs and dysregulated expression of known cytokine signaling regulators and master regulator of erythropoiesis including Socs3, Cd74, and Klf1 ( Figure 6A ). In contrast to the expression pattern of myeloid/erythroid lineage-specific TFs in myeloid progenitors, Aid 2/2 LSK cells showed a trend toward higher expression of Gata1 and variable Cebpa expression among each sample ( Figure 6A ), which might be due to differential transcriptional regulation in LSK and myeloid progenitor cells in Aid 2/2 mice.
Hierarchical clustering and 2-dimensional embedding by t-distributed stochastic neighbor embedding 21 demonstrated clear separation of Aid 2/2 LSKs from WT LSKs ( Figure 6B ; supplemental Figure 13A ).
Differential methylation analysis of eRRBS data using methylKit 22 for finding single-nucleotide differences (q value , 0.01 and methylation percentage difference of at least 25%) revealed overall hypermethylation phenotype in Aid 2/2 LSKs compared with WT LSKs with a total of 687 differentially methylated cytosine guanine dinucleotides (CpGs; DMCs) ( Figure 6C-D) , most of which are hypermethylated (596 CpGs of 687 CpGs) ( Figure 6D) . Moreover, over 90% of DMCs in CpG islands and CpG shores in Aid 2/2 LSKs relative to WT LSKs were hypermethylated ( Figure 6E ). Dominant hypermethylation was also observed in coding regions, especially in promoters and exons, in Aid 2/2 LSKs compared with WT LSKs ( Figure 6F ). The background distribution of all CpGs revealed the highest proportion in CpG islands (supplemental Figure 13B ). Of note, the proportion of CpG islands, CpG shores, promoters, and exons within hypermethylated CpGs in Aid 2/2 LSKs relative to WT LSKs were substantially higher than those within hypomethylated CpGs (supplemental Figure 13C) . In order to seek correlation between methylation status and gene expression, we focused on 270 genes with differentially methylated regions, which show average methylation difference over 10% in either coding sequence, intron, or promoter regions (supplemental Table 5 ). Although there was no significant overall correlation between gene expression and methylation, we identified 27 genes within this gene list which show overall hypermethylation and trend toward decreased expression in Aid 2/2 LSKs compared with WT LSKs (supplemental Figure 14) . These include Igfbp6 which functions as a tumor suppressor by inhibiting IGF-II-induced cell proliferation and survival, 23 and Dok3, a known tumor suppressor that inhibits tyrosine kinase signaling. 24, 25 Taken together, these data clearly indicate that Aid loss alters transcription of known regulators of erythropoiesis and promotes DNA methylation at loci with a role in transcriptional regulation.
Discussion
Recent studies reported TET family members and AID cooperate in active DNA demethylation processes. [5] [6] [7] [8] [9] Deletion of Tet2 in the hematopoietic compartment leads to enhanced HSC self-renewal and skewed differentiation toward myelomonocytic lineage in mice. [14] [15] [16] AID has also been reported to stabilize the pluripotent state in iPSC reprogramming, 19 demonstrating that AID is a critical player in stem cell biology. Taken together, these studies led us to hypothesize that AID might also regulate the hematopoietic system, especially in terms of HSC self-renewal and differentiation. In this study, we investigated the effect of Aid loss on both normal and malignant hematopoiesis, which allowed us to make some important observations. First, Aid loss leads to myeloid expansion and anemia due to altered erythroid differentiation and increased myeloid fate commitment, but this did not result in a myeloproliferative disease in vivo. Second, silencing of AID skewed differentiation toward the myelomonocytic lineage in human BM cells. Third, Aid loss does not contribute to enhanced HSC self-renewal or cooperate with Flt3-ITD in myeloid leukemogenesis. Finally, disruption of Aid causes altered transcription and methylation of regulators of erythropoiesis and tumor suppressors in BM HSPCs.
We showed that homozygous deletion of Aid in vivo leads to expansion of the myelomonocytic lineage. Given that AID cooperates with TET family members in DNA demethylation, these findings are consistent with previous reports showing that mice with Tet2 deletion demonstrated skewed differentiation toward myelomonocytic lineage. [14] [15] [16] 20 these results are in sharp contrast to Tet2 loss. Several possibilities may explain the differential effect of Aid loss and Tet2 loss on HSC regulation and myeloid transformation. Guo et al have recently reported that Apobec1 cooperates with Tet1 in neuronal activityinduced, region-specific, active DNA demethylation and subsequent gene expression in the dentate gyrus in mouse adult brain. 8 Moreover, within the AID/APOBEC family, APOBEC3 has been reported to possess cytidine deaminase activity. 27 These data suggest that Apobec1 and Apobec3 may function as redundant factors of Aid in active DNA demethylation processes. The exact biological significance of 5hmC remains to be delineated. Mendonca et al recently demonstrated that DNA modified with 5hmC generally exhibits an open chromatin configuration. 28 In addition, 5hmC was reported to accumulate at DNA damage foci induced by irradiation and colocalize with major DNA damage response proteins 53BP1 and gH2AX, indicating that the TET family members and 5hmC play essential roles in ensuring genome integrity. 29 Given that Tet2 loss causes decreased 5hmC whereas Aid loss induces accumulation of 5hmC ( Figure 1D ), it is possible that Tet2 loss and Aid loss demonstrate a different effect on hematopoiesis through the unique and specific biological role of 5hmC independent of DNA demethylation.
Alexandrov et al have reported that AID is responsible for kataegic mutations in various human cancers. 18 However, WES using DNA from either WT or Aid 2/2 nucleated PB cells failed to show any clusters of C.T or C.G mutations in Aid 2/2 cells. These data suggest that, although our Aid 2/2 mice model is a useful tool to elucidate the effect of Aid loss in normal and malignant hematopoiesis, it does not recapitulate the "Kataegis" phenotype observed in human cancers. We demonstrated that Aid 2/2 LSKs show altered expression of regulators of erythropoiesis and tumor suppressors, with concomitant DNA hypermethylation at some of these loci. Of note, enhanced DNA methylation in Aid 2/2 LSKs was preferentially seen at loci with potential capacity for transcriptional regulation, including CpG islands, CpG shores, and promoters, suggesting that DNA hypermethylation status in these regions caused by Aid loss may lead to epigenetic alterations which modulate transcriptional output. Indeed, CpG islands and particularly CpG shores have been described to be critical regulatory regions for hematopoiesis. 30 Consistent with this notion, we observed both hypermethylation and a trend toward decreased expression of known tumor suppressors in Aid 2/2 HSPCs. Although it is possible that this finding is due to the loss of active DNA demethylation machinery in Aid 2/2 cells, 9 there may be other possible mechanisms such as the potential loss of the passive DNA demethylation machinery in Aid 2/2 cells. In addition, bisulfite sequencing cannot discriminate between 5mC and 5hmC, raising the possibility that hypermethylation seen in some genetic loci in Aid 2/2 cells may include hydroxymethylation.
Further analysis and studies comparing the transcriptomes and methylomes of WT, Aid
2/2
, and Tet2 del/del LSKs may provide important insights for mechanisms and targets of epigenetic regulation critical for HSC biology.
In summary, we demonstrate that Aid is a critical regulator of myeloid and erythroid lineage differentiation in both the murine and human context. We also showed that, in contrast to Tet2, Aid does not have an essential role in HSC self-renewal or in myeloid transformation. Moreover, RNA-seq and eRRBS revealed that Aid modulates transcription and methylation of a subset of key hematopoietic regulators and tumor suppressors. Our data suggest that myeloid and erythroid lineage differentiation is regulated at least in part by epigenetic gene regulation through active DNA demethylation, whereas HSC self-renewal and myeloid transformation might be regulated through a novel biological role of 5hmC, which may be in part independent of DNA demethylation or regulated by other enzymes which mediate demethylation in HSCs. Further studies are required to elucidate the exact molecular targets of DNA demethylation relevant for hematopoietic cell differentiation and to uncover the unique biological significance of 5hmC, AID, and other enzymes involved in DNA demethylation downstream of Tet2 in HSC regulation and myeloid transformation.
